- Home
- TARA vs TZOO Comparison
TARA vs TZOO Comparison
Compare TARA & TZOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- TZOO
- Stock Information
- Founded
- TARA N/A
- TZOO 1998
- Country
- TARA United States
- TZOO United States
- Employees
- TARA N/A
- TZOO N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- TZOO Advertising
- Sector
- TARA Health Care
- TZOO Consumer Discretionary
- Exchange
- TARA Nasdaq
- TZOO Nasdaq
- Market Cap
- TARA 126.5M
- TZOO 136.1M
- IPO Year
- TARA N/A
- TZOO 2002
- Fundamental
- Price
- TARA $3.33
- TZOO $10.80
- Analyst Decision
- TARA Strong Buy
- TZOO Strong Buy
- Analyst Count
- TARA 7
- TZOO 4
- Target Price
- TARA $20.67
- TZOO $23.50
- AVG Volume (30 Days)
- TARA 450.2K
- TZOO 179.3K
- Earning Date
- TARA 08-05-2025
- TZOO 07-23-2025
- Dividend Yield
- TARA N/A
- TZOO N/A
- EPS Growth
- TARA N/A
- TZOO N/A
- EPS
- TARA N/A
- TZOO 0.90
- Revenue
- TARA N/A
- TZOO $87,822,000.00
- Revenue This Year
- TARA N/A
- TZOO $16.97
- Revenue Next Year
- TARA N/A
- TZOO $23.72
- P/E Ratio
- TARA N/A
- TZOO $11.99
- Revenue Growth
- TARA N/A
- TZOO 3.47
- 52 Week Low
- TARA $1.60
- TZOO $7.81
- 52 Week High
- TARA $10.48
- TZOO $24.85
- Technical
- Relative Strength Index (RSI)
- TARA 55.94
- TZOO 31.88
- Support Level
- TARA $3.25
- TZOO $12.73
- Resistance Level
- TARA $3.23
- TZOO $12.87
- Average True Range (ATR)
- TARA 0.17
- TZOO 0.59
- MACD
- TARA 0.04
- TZOO -0.23
- Stochastic Oscillator
- TARA 81.25
- TZOO 1.75
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About TZOO Travelzoo
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.